Lower adrenocortical and adrenomedullary responses to hypoglycemia in premenopausal women with systemic sclerosis

Journal of Rheumatology

Volumn 33, Issue 11, 2006, Pages 2235-2241

  Imrich, Richard ^a   Lukac, Jozef ^b   Rovensky, Jozef ^b   Radikova, Zofia ^a   Penesova, Adela ^a   Kvetnansky, Richard ^a   Huckova, Miroslava ^a   Vigas, Milan ^a   Macho, Ladislav ^a   Koska, Juraj ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

Adrenal cortex hormones; Hypoglycemia; Systemic sclerosis

Indexed keywords

ADRENALIN; ANDROSTENEDIONE; CORTICOTROPIN; GLUCOCORTICOID; GLUCOSE; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NORADRENALIN; PRASTERONE; PRASTERONE SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL CORTEX; ADRENAL CORTEX FUNCTION; ADRENAL FUNCTION; ADRENAL MEDULLA; ADRENALIN BLOOD LEVEL; ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DISEASE ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NORADRENALIN BLOOD LEVEL; NORADRENERGIC SYSTEM; PREMENOPAUSE; PRIORITY JOURNAL; STATISTICAL MODEL; SYSTEMIC SCLEROSIS;

ADRENAL CORTEX; ADRENAL MEDULLA; ADRENOCORTICOTROPIC HORMONE; ADULT; ANDROGENS; ANDROSTENEDIONE; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; PREMENOPAUSE; PROGESTERONE; SCLERODERMA, SYSTEMIC;

EID: 33751004129     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Generini S, Fiori G, Moggi Pignone A, Matucci Cerinic M, Cagnoni M. Systemic sclerosis. A clinical overview. Adv Exp Med Biol 1999;455:73-83.
2. Generini S, Matucci Cerinic M. Raynaud's phenomenon and vascular disease in systemic sclerosis. Adv Exp Med Biol 1999;455:93-100.
3. Chikanza IC, Grossman AB. Reciprocal interactions between the neuroendocrine and immune systems during inflammation. Rheum Dis Clin North Am 2000;26:693-711.
4. Bertinotti L, Bracci S, Nacci F, et al. The autonomic nervous system in systemic sclerosis. A review. Clin Rheumatol 2004;23:1-5.
5. Imrich R, Rovensky J, Malis F, et al. Low levels of dehydroepiandrosterone sulphate in plasma, and reduced sympathoadrenal response to hypoglycemia in premenopausal women with rheumatoid arthritis. Ann Rheum Dis 2005;64:202-6.
6. Cutolo M, Foppiani L, Prete C, et al. Hypothalamic-pituitary- adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999;26:282-8.
7. Straub RH, Paimela L, Peltomaa R, Scholmerich J, Leirisalo-Repo M. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002;46:654-62.
8. La Montagna G, Baruffo A, Buono G, Valentini G. Dehydroepiandrosterone sulphate serum levels in systemic sclerosis. Clin Exp Rheumatol 2001;19:21-6.
9. Straub RH, Zeuner M, Lock G, Scholmerich J, Lang B. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br J Rheumatol 1997;36:426-32.
10. Masi AT, Aldag JC, Jacobs JW. Rheumatoid arthritis: neuroendocrine immune integrated physiopathogenetic perspectives and therapy. Rheum Dis Clin North Am 2005;31:131-60.
11. Sapira JD, Rodnan GP, Scheib ET, Klaniecki T, Rizk M. Studies of endogenous catecholamines in patients with Raynaud's phenomenon secondary to progressive systemic sclerosis (scleroderma). Am J Med 1972;52:330-7.
12. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic-nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.
13. Baerwald CGO, Burmester GR, Krause A. Interactions of autonomic nervous, neuroendocrine, and immune systems in rheumatoid arthritis. Rheum Dis Clin North Am 2000;26:841-58.
14. Piascik MT, Soltis EE, Piascik MM, Macmillan LB. Alpha-adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates. Pharmacol Ther 1996;72:215-41.
15. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
16. Valentini G, Matucci Cerinic M, Bombardieri S. Consensus statement: core variables in the assessment of the patient with systemic sclerosis. Scleroderma Care Res 2004/2005;2:3-5.
17. Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977;21:625-36.
18. Herrmann M, Scholmerich J, Straub RH. Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro: a short tabular data collection. Ann NY Acad Sci 2002;966:166-86.
19. Weidler C, Struharova S, Schmidt M, Ugele B, Scholmerich J, Straub RH. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency. Arthritis Rheum 2005;52:1721-9.
20. Zietz B, Wengler I, Messmann H, Lock G, Scholmerich J, Straub RH. Early shifts of adrenal steroid synthesis before and after relief of short-term cholestasis. J Hepatol 2001;35:329-37.
21. Jaattela M, Ilvesmaki V, Voutilainen R, Stenman UH, Saksela E. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991;128:623-9.
22. Bertinotti L, Pietrini U, Del Rosso A, et al. The use of pupillometry in joint and connective tissue diseases. Ann NY Acad Sci 2002;966:446-55.
23. Straub RH, Baerwald CG, Wahle M, Janig W. Autonomic dysfunction in rheumatic diseases. Rheum Dis Clin North Am 2005;31:61-75.
24. Straub RH, Zeuner M, Lock G, et al. Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematusus and systemic sclerosis. J Rheumatol 1996;23:87-92.
25. Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 2003;305:800-11.
26. Fagius J, Niklasson F, Berne C. Sympathetic outflow in human muscle nerves increases during hypoglycemia. Diabetes 1986;35:1124-9.
27. Dessein PH, Joffe BI, Metz RM, Millar DL, Lawson M, Stanwix AE. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 1992;93:143-50.
28. Kazzam E, Caidahl K, Hedner T, Hedner J, Waldenstrom A. Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis. Scand J Rheumatol 1999;28:238-43.
29. Hermosillo AG, Ortiz R, Dabague J, Casanova JM, Martinez-Lavin M. Autonomic dysfunction in diffuse scleroderma vs CREST: an assessment by computerized heart rate variability. J Rheumatol 1994;21:1849-54.
30. Morelli S, Sgreccia A, Ferrante L, et al. Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma). Int J Cardiol 1996;57:151-60.
31. Ferri C, Emdin M, Giuggioli D, et al. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rneumatol 1997;36:669-76.
32. Pancera P, Sansone S, Presciuttini B, et al. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Clin Sci Lond 1999;96:49-57.
33. Kaye DM, Gruskin S, Smith AI, Esler MD. Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation. Br J Pharmacol 2000;130:1060-4.
34. Pedersen PB, Hogenhaven H. Penicillamin-induced neuropathy in rheumatoid arthritis. Acta Neurol Scand 1990;81:188-90.
35. Tseng CJ, Chan JY, Lo WC, Jan CR. Modulation of catecholamine release by endogenous adenosine in the rat adrenal medulla. J Biomed Sci 2001;8:389-94.
36. Corssmit EP, Romijn JA, Endert E, Sauerwein HP. Modulation of glucose production by indomethacin and pentoxifylline in healthy humans. Metabolism 1996;45:1458-65.